CN110734988A - 一种耐甲氧西林金黄色葡萄球菌(mrsa)核酸恒温扩增方法 - Google Patents
一种耐甲氧西林金黄色葡萄球菌(mrsa)核酸恒温扩增方法 Download PDFInfo
- Publication number
- CN110734988A CN110734988A CN201810803884.2A CN201810803884A CN110734988A CN 110734988 A CN110734988 A CN 110734988A CN 201810803884 A CN201810803884 A CN 201810803884A CN 110734988 A CN110734988 A CN 110734988A
- Authority
- CN
- China
- Prior art keywords
- meca
- mrsa
- rna
- rrna
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000191967 Staphylococcus aureus Species 0.000 title claims abstract description 106
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 title claims abstract description 99
- 229960003085 meticillin Drugs 0.000 title claims abstract description 99
- 238000000034 method Methods 0.000 title claims abstract description 50
- 108020004707 nucleic acids Proteins 0.000 title abstract description 81
- 150000007523 nucleic acids Chemical class 0.000 title abstract description 81
- 102000039446 nucleic acids Human genes 0.000 title abstract description 81
- 238000011901 isothermal amplification Methods 0.000 title description 16
- 238000001514 detection method Methods 0.000 claims abstract description 191
- 238000006243 chemical reaction Methods 0.000 claims abstract description 93
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 78
- 230000003321 amplification Effects 0.000 claims abstract description 76
- 239000000523 sample Substances 0.000 claims description 216
- 239000002773 nucleotide Substances 0.000 claims description 26
- 125000003729 nucleotide group Chemical group 0.000 claims description 26
- 238000011895 specific detection Methods 0.000 claims description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 238000002405 diagnostic procedure Methods 0.000 claims description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 136
- 239000013615 primer Substances 0.000 description 131
- 239000000243 solution Substances 0.000 description 92
- 239000003814 drug Substances 0.000 description 49
- 229940079593 drug Drugs 0.000 description 48
- 108020004414 DNA Proteins 0.000 description 42
- 239000013641 positive control Substances 0.000 description 40
- 239000013642 negative control Substances 0.000 description 25
- 102000004190 Enzymes Human genes 0.000 description 21
- 108090000790 Enzymes Proteins 0.000 description 21
- 102100034343 Integrase Human genes 0.000 description 19
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 19
- 101710137500 T7 RNA polymerase Proteins 0.000 description 19
- 101150008979 mecA gene Proteins 0.000 description 18
- 239000011324 bead Substances 0.000 description 16
- 230000035945 sensitivity Effects 0.000 description 15
- 238000010790 dilution Methods 0.000 description 14
- 239000012895 dilution Substances 0.000 description 14
- 239000002987 primer (paints) Substances 0.000 description 14
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 13
- 239000007995 HEPES buffer Substances 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 238000005406 washing Methods 0.000 description 13
- 238000001917 fluorescence detection Methods 0.000 description 12
- 238000000338 in vitro Methods 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 238000004321 preservation Methods 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 239000003761 preservation solution Substances 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- 206010059866 Drug resistance Diseases 0.000 description 4
- 108020004566 Transfer RNA Proteins 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000002860 competitive effect Effects 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229960001019 oxacillin Drugs 0.000 description 3
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 108700022487 rRNA Genes Proteins 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000011896 sensitive detection Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 239000004246 zinc acetate Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 208000037942 Methicillin-resistant Staphylococcus aureus infection Diseases 0.000 description 1
- 206010048723 Multiple-drug resistance Diseases 0.000 description 1
- 239000013616 RNA primer Substances 0.000 description 1
- -1 SAT nucleic acid Chemical class 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 102100029677 Trehalase Human genes 0.000 description 1
- 108010087472 Trehalase Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 206010048629 Wound secretion Diseases 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000012938 design process Methods 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002683 reaction inhibitor Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
SA检测结果 | mecA检测结果 | MRSA结果判断 |
+ | + | + |
— | + | — |
+ | — | — |
— | — | — |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810803884.2A CN110734988B (zh) | 2018-07-20 | 2018-07-20 | 一种耐甲氧西林金黄色葡萄球菌(mrsa)核酸恒温扩增方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810803884.2A CN110734988B (zh) | 2018-07-20 | 2018-07-20 | 一种耐甲氧西林金黄色葡萄球菌(mrsa)核酸恒温扩增方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110734988A true CN110734988A (zh) | 2020-01-31 |
CN110734988B CN110734988B (zh) | 2024-06-18 |
Family
ID=69234818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810803884.2A Active CN110734988B (zh) | 2018-07-20 | 2018-07-20 | 一种耐甲氧西林金黄色葡萄球菌(mrsa)核酸恒温扩增方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110734988B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020142852A1 (en) * | 2019-01-11 | 2020-07-16 | Uti Limited Partnership | Novel assay for mrsa detection directly from clinical samples |
CN112410343A (zh) * | 2020-12-19 | 2021-02-26 | 郑州大学 | 基于crispr的试剂盒及其应用 |
CN114317787A (zh) * | 2021-12-29 | 2022-04-12 | 成都大学 | 吸附磁珠及其试剂盒和用途以及检测金黄色葡萄球菌的方法 |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020098492A1 (en) * | 2000-05-29 | 2002-07-25 | Toshiki Taya | Oligonucleotides and method for detection of meca gene of methicillin-resistant staphylococcus aureus |
US20040241824A1 (en) * | 2001-03-15 | 2004-12-02 | Jacques Schrenzel | Method for the direct detection of methicillin-resistant staphylococcus aureus |
CN102399877A (zh) * | 2011-11-09 | 2012-04-04 | 泰普生物科学(中国)有限公司 | 一种金黄色葡萄球菌耐甲氧西林菌株pcr检测试剂盒 |
EP2488664A2 (en) * | 2009-10-13 | 2012-08-22 | Syntezza Molecular Detection Israel Ltd | Methods and compositions for amplifying target sequences from nucleic acid samples |
CN102719542A (zh) * | 2012-06-19 | 2012-10-10 | 上海仁度生物科技有限公司 | 霍乱弧菌(vc)的实时荧光核酸恒温扩增检测试剂盒 |
JP2013048620A (ja) * | 2011-08-03 | 2013-03-14 | Toyobo Co Ltd | メチシリン耐性黄色ブドウ球菌を検出するためのプライマーおよびプローブ、ならびに、それらを用いたメチシリン耐性黄色ブドウ球菌の検出方法 |
CN103215386A (zh) * | 2013-05-08 | 2013-07-24 | 上海仁度生物科技有限公司 | 一种肠道病毒ev核酸恒温扩增方法 |
CN103421897A (zh) * | 2012-08-07 | 2013-12-04 | 上海仁度生物科技有限公司 | 针对志贺氏菌(sh)的rna恒温扩增核酸检测试剂盒 |
US20150087545A1 (en) * | 2013-09-23 | 2015-03-26 | Quest Diagnostics Investments Incorporated | Detection of methicillin-resistant staphylococcus aureus in biological samples |
CN105385780A (zh) * | 2015-12-29 | 2016-03-09 | 杭州迪安生物技术有限公司 | 耐甲氧西林金黄色葡萄球菌快速检测的试剂盒及其应用 |
CN105624329A (zh) * | 2014-10-29 | 2016-06-01 | 上海仁度生物科技有限公司 | 单纯疱疹病毒1型实时荧光核酸恒温扩增检测试剂盒 |
CN106222248A (zh) * | 2016-07-08 | 2016-12-14 | 宁波基内生物技术有限公司 | 一种检测耐甲氧西林金黄色葡萄球菌耐药性基因的引物、探针、方法及试剂盒 |
US20180135108A1 (en) * | 2014-01-20 | 2018-05-17 | Board Of Trustees Of Michigan State University | Method for detecting bacterial and fungal pathogens |
CN108265125A (zh) * | 2016-12-30 | 2018-07-10 | 上海仁度生物科技有限公司 | 一种猪瘟病毒(csfv)实时荧光核酸恒温扩增检测试剂盒 |
-
2018
- 2018-07-20 CN CN201810803884.2A patent/CN110734988B/zh active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020098492A1 (en) * | 2000-05-29 | 2002-07-25 | Toshiki Taya | Oligonucleotides and method for detection of meca gene of methicillin-resistant staphylococcus aureus |
US20040241824A1 (en) * | 2001-03-15 | 2004-12-02 | Jacques Schrenzel | Method for the direct detection of methicillin-resistant staphylococcus aureus |
EP2488664A2 (en) * | 2009-10-13 | 2012-08-22 | Syntezza Molecular Detection Israel Ltd | Methods and compositions for amplifying target sequences from nucleic acid samples |
JP2013048620A (ja) * | 2011-08-03 | 2013-03-14 | Toyobo Co Ltd | メチシリン耐性黄色ブドウ球菌を検出するためのプライマーおよびプローブ、ならびに、それらを用いたメチシリン耐性黄色ブドウ球菌の検出方法 |
CN102399877A (zh) * | 2011-11-09 | 2012-04-04 | 泰普生物科学(中国)有限公司 | 一种金黄色葡萄球菌耐甲氧西林菌株pcr检测试剂盒 |
CN102719542A (zh) * | 2012-06-19 | 2012-10-10 | 上海仁度生物科技有限公司 | 霍乱弧菌(vc)的实时荧光核酸恒温扩增检测试剂盒 |
CN103421897A (zh) * | 2012-08-07 | 2013-12-04 | 上海仁度生物科技有限公司 | 针对志贺氏菌(sh)的rna恒温扩增核酸检测试剂盒 |
CN103215386A (zh) * | 2013-05-08 | 2013-07-24 | 上海仁度生物科技有限公司 | 一种肠道病毒ev核酸恒温扩增方法 |
US20150087545A1 (en) * | 2013-09-23 | 2015-03-26 | Quest Diagnostics Investments Incorporated | Detection of methicillin-resistant staphylococcus aureus in biological samples |
US20180135108A1 (en) * | 2014-01-20 | 2018-05-17 | Board Of Trustees Of Michigan State University | Method for detecting bacterial and fungal pathogens |
CN105624329A (zh) * | 2014-10-29 | 2016-06-01 | 上海仁度生物科技有限公司 | 单纯疱疹病毒1型实时荧光核酸恒温扩增检测试剂盒 |
CN105385780A (zh) * | 2015-12-29 | 2016-03-09 | 杭州迪安生物技术有限公司 | 耐甲氧西林金黄色葡萄球菌快速检测的试剂盒及其应用 |
CN106222248A (zh) * | 2016-07-08 | 2016-12-14 | 宁波基内生物技术有限公司 | 一种检测耐甲氧西林金黄色葡萄球菌耐药性基因的引物、探针、方法及试剂盒 |
CN108265125A (zh) * | 2016-12-30 | 2018-07-10 | 上海仁度生物科技有限公司 | 一种猪瘟病毒(csfv)实时荧光核酸恒温扩增检测试剂盒 |
Non-Patent Citations (11)
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020142852A1 (en) * | 2019-01-11 | 2020-07-16 | Uti Limited Partnership | Novel assay for mrsa detection directly from clinical samples |
CN112410343A (zh) * | 2020-12-19 | 2021-02-26 | 郑州大学 | 基于crispr的试剂盒及其应用 |
CN112410343B (zh) * | 2020-12-19 | 2023-02-21 | 郑州大学 | 基于crispr的试剂盒及其应用 |
CN114317787A (zh) * | 2021-12-29 | 2022-04-12 | 成都大学 | 吸附磁珠及其试剂盒和用途以及检测金黄色葡萄球菌的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110734988B (zh) | 2024-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2596059C (en) | Method of quantitatively analysing microorganism targeting rrna | |
CN102367475B (zh) | 不同血清型霍乱弧菌的m-PCR检测试剂盒及检测方法 | |
US20220098645A1 (en) | Fast and portable microfluidic detection system as an alternative to salmonella's classical culture method | |
CN110734988B (zh) | 一种耐甲氧西林金黄色葡萄球菌(mrsa)核酸恒温扩增方法 | |
CN112458212A (zh) | 同时检测甲型流感病毒、乙型流感病毒及呼吸道合胞病毒的试剂盒 | |
CN112359125A (zh) | 一种快速检测格特隐球菌的方法 | |
CN116042902A (zh) | 一种同时检测六种念珠菌的实时荧光核酸恒温扩增检测试剂盒及其专用引物和探针 | |
CN105567802A (zh) | 肺炎衣原体荧光pcr检测试剂盒 | |
CN104342487B (zh) | 支原体核酸恒温扩增方法 | |
CN108070638B (zh) | 一种检测恙虫病东方体的重组酶聚合酶恒温扩增方法、其专用引物和探针及用途 | |
CN106939330B (zh) | 鸟-胞分枝杆菌的实时荧光核酸恒温扩增检测试剂盒及其专用引物与探针 | |
CN109457020B (zh) | 耐药性检测组合物、耐药性检测试剂盒及耐药性检测方法 | |
CN103215386B (zh) | 一种肠道病毒ev核酸恒温扩增方法 | |
CN106916903A (zh) | 结核分枝杆菌85B mRNA的实时荧光RT‑PCR检测方法及试剂盒 | |
CN116479150A (zh) | 单管一步法RPA-Cas12a/Cas13a快速检测耐甲氧西林金黄色葡萄球菌 | |
CN114480689A (zh) | 检测肺炎链球菌的rpa方法、其专用引物和探针及用途 | |
US20150140548A1 (en) | Extraction control for rna | |
CN102936621A (zh) | 蜡样芽孢杆菌的检测方法及试剂盒 | |
CN104032000B (zh) | 一种蜡样芽孢杆菌的检测方法及试剂盒 | |
CN110669854A (zh) | 鉴定金黄色葡萄球菌及其耐药性的引物探针组合 | |
CN105400878B (zh) | 一组用于表皮葡萄球菌实时荧光pcr检测的特异性引物和探针 | |
CN114164296B (zh) | 一种用于检测寡雄腐霉菌的引物探针组合物、试剂盒及应用和检测方法 | |
CN107723376B (zh) | 一种检测普氏立克次体的rpa方法、其专用引物和探针及用途 | |
CN102643901B (zh) | 一种检测甲型副伤寒沙门菌的rt-lamp试剂盒 | |
CN118256634A (zh) | 检测幽门螺旋杆菌VacA-M1和VacA-M2的引物探针组、试剂盒和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: Room a, 3 / F, building B, No. 528 Ruiqing Road, East District, Zhangjiang hi tech park, Pudong New Area, Shanghai 201201 Applicant after: Shanghai Rendu Biotechnology Co.,Ltd. Address before: Room a, 3 / F, building B, No. 528 Ruiqing Road, East District, Zhangjiang hi tech park, Pudong New Area, Shanghai 201201 Applicant before: SHANGHAI RENDU BIOTECHNOLOGY Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Room B, building 15, No. 528 Ruiqing Road, East District, Zhangjiang hi tech park, Pudong New Area, Shanghai, 201201 Applicant after: Shanghai Rendu Biotechnology Co.,Ltd. Address before: Room a, 3 / F, building B, No. 528 Ruiqing Road, East District, Zhangjiang hi tech park, Pudong New Area, Shanghai 201201 Applicant before: Shanghai Rendu Biotechnology Co.,Ltd. |
|
CB02 | Change of applicant information | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Ju Jinliang Inventor after: Yu Minghui Inventor after: Cui Zhenling Inventor before: Shang Xuejun Inventor before: Ju Jinliang Inventor before: Yu Minghui Inventor before: Cui Zhenling |
|
CB03 | Change of inventor or designer information |